MDS with Excess Blasts — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Myelodysplastic syndrome
Pancytopenia with macrocytosis, dysplastic features (pseudo-Pelger-Huët), hypercellular marrow with trilineage dysplasia, 8% blasts, and complex karyotype is MDS-EB1 (excess blasts 1, 5-9%). Complex karyotype confers high-risk IPSS-R. Treatment: hypomethylating agent (azacitidine — AZA-001 trial) or allo-SCT if eligible. Luspatercept for transfusion-dependent anaemia with ring sideroblasts.
Reference: WHO – 2022 – MDS; ELN 2024; AZA-001 Trial